Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Sectors

Jiliguala fills up series C round

Tencent took part in a round sized at nearly $100m for the English language learning platform, which counts Bertelsmann among its earlier investors.


Jan 19, 2021

Everlywell revs up with $75m

HealthQuest Capital supplied $75m for the medical test provider, which counts The Chernin Group as an investor, at a flat $1.3bn valuation.

Jan 19, 2021

Nyle nabs new funding

DA Consortium, Gree Ventures, Hakuhodo DY Media Partners and SBI Group were among the backers in a $48.2m round for the marketing, media and ride hailing service operator.

Jan 19, 2021

Didi Mobility Japan goes local with fresh funding

The mobility service provider will use the $50.1m cash it secured from SoftBank and Didi Chuxing to expand from Chinese tourists to local Japanese users.

Jan 19, 2021

Budbee gets $63m cash delivery

H&M Co:Lab reinvested in the last-mile delivery service as part of a round that will support its international expansion and the strengthening of its technology.

Jan 19, 2021

Verizon leads Vdoo series B to $57m

Verizon Ventures was among the investors that added $25m to a round already featuring Dell Technologies Capital, MS&AD Ventures and NTT Docomo Ventures.

Jan 19, 2021

BlueSphere Bio brings in series B funding

UPMC-backed cancer immunotherapy developer BlueSphere Bio has attracted an initial $45.6m in series B funding towards a $105m target for its close.

Jan 19, 2021

Brazil adds triple fundraisings

The three funds comes as Daniel de Macedo switches role and a new trade body committee is set up for CVCs.

Jan 19, 2021

Sector report: Transport

If the sector can weather the economic storm, it has huge potential.

Jan 19, 2021

J-Pharma jacks series D up to $21m

Fidelity provided a $4.8m second tranche after a first close featuring vehicles for Kyushu University and Osaka University.

Jan 19, 2021

BlueSphere Bio brings in $45.6m

Pitt spinout BlueSphere Bio has attracted an initial $45.6m in series B funding towards a $105m target size.

Jan 19, 2021

Biohaven brings Kleo into the fold

Existing shareholder Biohaven has agreed to purchase the remaining stake in Kleo Pharmaceuticals, a Yale spinout it first backed in 2016.

Jan 19, 2021
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here